Retinitis Pigmentosa (Retinitis) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4170328
- 154 Pages
- February 2021
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Retinitis Pigmentosa (Retinitis) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Retinitis Pigmentosa (Retinitis) market segmented into
General Treatment
Traditional Chinese Medicine
Gene Therapy
The Surgical Treatment
Others
Based on the end-use, the global Retinitis Pigmentosa (Retinitis) market classified into
Hospitals
Eye Clinics
Others
Based on geography, the global Retinitis Pigmentosa (Retinitis) market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Sanofi
Amgen
Amarantus Bioscience Holdings
Acucela
Applied Genetic Technologies Corp
Asklepios BioPharmaceutical
Astellas Pharma
Caladrius Biosciences
Dompe Farmaceutici SpA
Dormant Projects
GenSight Biologics SA
Grupo Ferrer Internacional SA
ID Pharma
InFlectis BioScience
Ionis Pharmaceuticals
Mimetogen Pharmaceuticals
M's Science Corp
Nanovector srl
Novartis AG
Novelion Therapeutics
ProQR Therapeutics
ReNeuron Group Plc
SanBio
Shire (Takeda Pharmaceutical)
Spark Therapeutics
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RETINITIS PIGMENTOSA (RETINITIS) INDUSTRY
2.1 Summary about Retinitis Pigmentosa (Retinitis) Industry
2.2 Retinitis Pigmentosa (Retinitis) Market Trends
2.2.1 Retinitis Pigmentosa (Retinitis) Production & Consumption Trends
2.2.2 Retinitis Pigmentosa (Retinitis) Demand Structure Trends
2.3 Retinitis Pigmentosa (Retinitis) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 General Treatment
4.2.2 Traditional Chinese Medicine
4.2.3 Gene Therapy
4.2.4 The Surgical Treatment
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Eye Clinics
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 General Treatment
5.2.2 Traditional Chinese Medicine
5.2.3 Gene Therapy
5.2.4 The Surgical Treatment
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Eye Clinics
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 General Treatment
6.2.2 Traditional Chinese Medicine
6.2.3 Gene Therapy
6.2.4 The Surgical Treatment
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Eye Clinics
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 General Treatment
7.2.2 Traditional Chinese Medicine
7.2.3 Gene Therapy
7.2.4 The Surgical Treatment
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Eye Clinics
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 General Treatment
8.2.2 Traditional Chinese Medicine
8.2.3 Gene Therapy
8.2.4 The Surgical Treatment
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Eye Clinics
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 General Treatment
9.2.2 Traditional Chinese Medicine
9.2.3 Gene Therapy
9.2.4 The Surgical Treatment
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Eye Clinics
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sanofi
10.1.2 Amgen
10.1.3 Amarantus Bioscience Holdings
10.1.4 Acucela
10.1.5 Applied Genetic Technologies Corp
10.1.6 Asklepios BioPharmaceutical
10.1.7 Astellas Pharma
10.1.8 Caladrius Biosciences
10.1.9 Dompe Farmaceutici SpA
10.1.10 Dormant Projects
10.1.11 GenSight Biologics SA
10.1.12 Grupo Ferrer Internacional SA
10.1.13 ID Pharma
10.1.14 InFlectis BioScience
10.1.15 Ionis Pharmaceuticals
10.1.16 Mimetogen Pharmaceuticals
10.1.17 M's Science Corp
10.1.18 Nanovector srl
10.1.19 Novartis AG
10.1.20 Novelion Therapeutics
10.1.21 ProQR Therapeutics
10.1.22 ReNeuron Group Plc
10.1.23 SanBio
10.1.24 Shire (Takeda Pharmaceutical)
10.1.25 Spark Therapeutics
10.2 Retinitis Pigmentosa (Retinitis) Sales Date of Major Players (2017-2020e)
10.2.1 Sanofi
10.2.2 Amgen
10.2.3 Amarantus Bioscience Holdings
10.2.4 Acucela
10.2.5 Applied Genetic Technologies Corp
10.2.6 Asklepios BioPharmaceutical
10.2.7 Astellas Pharma
10.2.8 Caladrius Biosciences
10.2.9 Dompe Farmaceutici SpA
10.2.10 Dormant Projects
10.2.11 GenSight Biologics SA
10.2.12 Grupo Ferrer Internacional SA
10.2.13 ID Pharma
10.2.14 InFlectis BioScience
10.2.15 Ionis Pharmaceuticals
10.2.16 Mimetogen Pharmaceuticals
10.2.17 M's Science Corp
10.2.18 Nanovector srl
10.2.19 Novartis AG
10.2.20 Novelion Therapeutics
10.2.21 ProQR Therapeutics
10.2.22 ReNeuron Group Plc
10.2.23 SanBio
10.2.24 Shire (Takeda Pharmaceutical)
10.2.25 Spark Therapeutics
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Retinitis Pigmentosa (Retinitis) Product Type Overview
2.Table Retinitis Pigmentosa (Retinitis) Product Type Market Share List
3.Table Retinitis Pigmentosa (Retinitis) Product Type of Major Players
4.Table Brief Introduction of Sanofi
5.Table Brief Introduction of Amgen
6.Table Brief Introduction of Amarantus Bioscience Holdings
7.Table Brief Introduction of Acucela
8.Table Brief Introduction of Applied Genetic Technologies Corp
9.Table Brief Introduction of Asklepios BioPharmaceutical
10.Table Brief Introduction of Astellas Pharma
11.Table Brief Introduction of Caladrius Biosciences
12.Table Brief Introduction of Dompe Farmaceutici SpA
13.Table Brief Introduction of Dormant Projects
14.Table Brief Introduction of GenSight Biologics SA
15.Table Brief Introduction of Grupo Ferrer Internacional SA
16.Table Brief Introduction of ID Pharma
17.Table Brief Introduction of InFlectis BioScience
18.Table Brief Introduction of Ionis Pharmaceuticals
19.Table Brief Introduction of Mimetogen Pharmaceuticals
20.Table Brief Introduction of M's Science Corp
21.Table Brief Introduction of Nanovector srl
22.Table Brief Introduction of Novartis AG
23.Table Brief Introduction of Novelion Therapeutics
24.Table Brief Introduction of ProQR Therapeutics
25.Table Brief Introduction of ReNeuron Group Plc
26.Table Brief Introduction of SanBio
27.Table Brief Introduction of Shire (Takeda Pharmaceutical)
28.Table Brief Introduction of Spark Therapeutics
29.Table Products & Services of Sanofi
30.Table Products & Services of Amgen
31.Table Products & Services of Amarantus Bioscience Holdings
32.Table Products & Services of Acucela
33.Table Products & Services of Applied Genetic Technologies Corp
34.Table Products & Services of Asklepios BioPharmaceutical
35.Table Products & Services of Astellas Pharma
36.Table Products & Services of Caladrius Biosciences
37.Table Products & Services of Dompe Farmaceutici SpA
38.Table Products & Services of Dormant Projects
39.Table Products & Services of GenSight Biologics SA
40.Table Products & Services of Grupo Ferrer Internacional SA
41.Table Products & Services of ID Pharma
42.Table Products & Services of InFlectis BioScience
43.Table Products & Services of Ionis Pharmaceuticals
44.Table Products & Services of Mimetogen Pharmaceuticals
45.Table Products & Services of M's Science Corp
46.Table Products & Services of Nanovector srl
47.Table Products & Services of Novartis AG
48.Table Products & Services of Novelion Therapeutics
49.Table Products & Services of ProQR Therapeutics
50.Table Products & Services of ReNeuron Group Plc
51.Table Products & Services of SanBio
52.Table Products & Services of Shire (Takeda Pharmaceutical)
53.Table Products & Services of Spark Therapeutics
54.Table Market Distribution of Major Players
55.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
56.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
57.Table Global Retinitis Pigmentosa (Retinitis) Market Forecast (Million USD) by Region 2021f-2026f
58.Table Global Retinitis Pigmentosa (Retinitis) Market Forecast (Million USD) Share by Region 2021f-2026f
59.Table Global Retinitis Pigmentosa (Retinitis) Market Forecast (Million USD) by Demand 2021f-2026f
60.Table Global Retinitis Pigmentosa (Retinitis) Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
